Cencora, Inc.
Explore Cencora
Core profile pages, annual revenue records, and related research hubs for this company.
Cencora, Inc.
Explore Cencora
Core profile pages, annual revenue records, and related research hubs for this company.
Business Model Analysis
Annual Revenue: $321.3B
Cencora makes money primarily through high-volume pharmaceutical wholesale distribution. It also earns revenue from specialty distribution, provider services, international distribution, biopharma logistics, commercialization services, and animal-health distribution.
Cencora's strategy is to protect core U.S. distribution scale while expanding specialty, international healthcare solutions, biopharma commercialization, cold-chain logistics, and services that are more valuable to manufacturers and providers than basic wholesale movement.
Cencora earns from pharmaceutical wholesale distribution and specialty services.
Drug volumes, specialty mix, and distribution fees drive results.
Specialty growth and distribution margins are key Cencora variables.
Logistics and working-capital intensive.